Provista Diagnostics Receives $2,564,948 New Funding Round

  • Feed Type
  • Date
    10/28/2016
  • Company Name
    Provista Diagnostics
  • Mailing Address
    55 Broad Street 18th Floor New York, NY 10004 USA
  • Company Description
    Provista Diagnostics, Inc. develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes.
  • Website
    http://www.provistadx.com
  • Transaction Type
    Venture Equity, Debt
  • Transaction Amount
    $2,564,948
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy